Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : rAd26
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Approved FDF
Sponsor : Russian Direct Investment Fund
Deal Size : Inapplicable
Deal Type : Inapplicable
Stelis Biopharma Gets CDSCO Nod to Export 50 Million Doses of Sputnik Light Vaccine
Details : Sputnik Light (rAd26) vaccine demonstrates 91.6% efficacy rate against coronavirus, the world’s first registered vaccine against the novel coronavirus infection, is now approved for use in over 50 countries.
Product Name : Sputnik Light
Product Type : Vaccine
Upfront Cash : Inapplicable
December 21, 2021
Lead Product(s) : rAd26
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Approved FDF
Sponsor : Russian Direct Investment Fund
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
